摘要
目的:比较腹股沟疝采用Lichtenstein修补术和开放式腹膜前间隙修补术的临床效果和安全性。方法:将我院普外科收治的132例腹股沟疝患者随机分为两组,每组66例。一组患者采用Lichtenstein修补术进行治疗,另外一组患者采用开放式腹膜前间隙修补术进行治疗,对比两组平均手术时间、平均术中出血量、平均术后下床时间、平均术后住院时间、平均术后恢复时间;对比两组患者术后各种并发症的发生情况和1年内复发情况。结果:腹膜前间隙组平均手术时间、平均术后下床时间、平均术后住院时间、平均术后恢复时间略短于Lichtenstein组,平均术中出血量略少于Lichtenstein组,但差异无统计学意义(P>0.05);腹膜前间隙组患者各种并发症发生率及术后1年内复发率明显低于Lichtenstein组,差异具有统计学意义(P<0.05)。结论:腹股沟疝采用开放式腹膜前间隙修补术和Lichtenstein修补术治疗的临床效果均较好,但开放式腹膜前间隙修补术的并发症发生率和1年内复发率更低,临床优势更明显。
Objective: To compare the clinical effect and safety of Lichtenstein repair and open preperitoneal space repair for inguinal hernia. Methods: 132 patients with inguinal hernia in the department of general surgery in our hospital were randomly divided into two groups, 66 cases in each group. A group of patients were given Lichtenstein repair for the treatment, and another group were received open preperitoneal space repair operation. The average operation time, average bleeding volume, mean postoperative bed time and the average hospitalization time and average recovery time of the two groups were compared. The occurrence rate of postoperative complications and recurrence rate at one-year between the two groups were also analyzed. Results: The mean operation time, the average postoperative bed time, the average hospitalization time, the average recovery time and the average intraoperative bleeding volume in the preperitoneal space group were slightly shorter than those of the Lichtenstein group, while there was no difference between the two groups(P〈0.05). The occurrence rate of postoperative complications and recurrence rate at one-year of the preperitoneal space group were both significantly lower than those of the Lichtenstein group, and there were both statistically difference(P〈0.05). Conclusions: The open preperitoneal space repair and Lichtenstein repair treatment can both get well effect for the treatment of inguinal hernia, while the open preperitonealspace repair operation has a lower occurrence rate of postoperative complications and the recurrence rate at one-year, which shows more obviously clinical advantages.
出处
《现代生物医学进展》
CAS
2015年第36期7124-7127,共4页
Progress in Modern Biomedicine
基金
国家自然科学基金青年项目(81403451)